Chai Biao-Xin, Neubig Richard R, Millhauser Glenn L, Thompson Darren A, Jackson Pilgrim J, Barsh Gregory S, Dickinson Chris J, Li Ji-Yao, Lai Yu-Mei, Gantz Ira
Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0682, USA.
Peptides. 2003 Apr;24(4):603-9. doi: 10.1016/s0196-9781(03)00104-9.
Agouti and agouti-related protein (AgRP) are endogenous antagonists of the melanocortin receptors (MCxR). Previous data showed that recombinant full-length agouti and a synthetic fragment of AgRP, AgRP (83-132), are inverse agonists at the MC1R and MC4R, respectively. This study demonstrates the smaller analogs AgRP (87-120) and ASIP [90-132 (L89Y)], and short peptides Yc[CRFFNAFC]Y and Qc[CRFFRSAC]S are also MC4R inverse agonists. Furthermore, the relative affinity of the series of MC4R ligands for displacement of radiolabeled antagonist 125I-AgRP (86-132) versus radiolabeled agonist 125I-NDP-MSH did not correlate with ligand efficacy, which is more consistent with an induced-fit model than a simple two-state model of MC4R activation. These data shed new light on the determinants and mechanism of inverse agonism at the MC4R.